EUVIMEDEUVIMED entdecken
Open Access

The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience

Noriyoshi Iriyama, Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Kazuhide Iizuka, Shimon Otake, Takashi Hamada, Takashi Koike, Kazuya Kurihara, Toshihide Endo, Hideki Nakamura

Journal of Clinical and Experimental Hematopathology · 2025

DOI: 10.3960/jslrt.25010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2025. Verfasst von Noriyoshi Iriyama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, T-Cell, PeripheralAntineoplastic Combined Chemotherapy ProtocolsHumansDoxorubicinFemaleMaleMiddle AgedCyclophosphamideAgedAdultVincristinePrednisoneTreatment OutcomeRetrospective StudiesSurvival RateAged, 80 and over

Stichwörter der Autor:innen

doxorubicinperipheral T-cell lymphomapirarubicinprognosis

Substanzen

DoxorubicinpirarubicinCyclophosphamideVincristinePrednisone

Autor:innen und Institutionen

  • Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Department of Hematology and Rheumatology, National Hospital Organization Saitama Hospital, Saitama, Japan.
  • Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.

Zitieren

APA

Iriyama, N., Miura, K., Takahashi, H., Nakagawa, M., Iizuka, K., Otake, S., Hamada, T., Koike, T., Kurihara, K., Endo, T., & Nakamura, H. (2025). The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.25010

Vancouver

Iriyama N, Miura K, Takahashi H, Nakagawa M, Iizuka K, Otake S, et al. The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience. Journal of Clinical and Experimental Hematopathology. 2025. doi:10.3960/jslrt.25010

BibTeX
@article{Iriyama2025,
  author = {Iriyama, Noriyoshi and Miura, Katsuhiro and Takahashi, Hiromichi and Nakagawa, Masaru and Iizuka, Kazuhide and Otake, Shimon and Hamada, Takashi and Koike, Takashi and Kurihara, Kazuya and Endo, Toshihide and Nakamura, Hideki},
  title = {The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2025},
  doi = {10.3960/jslrt.25010}
}
Kostenlos starten →